Key result
Periostin injection increases ECG RS height by ~38% while reducing ventricular NaV1.5 expression in rats.
Why the study?
A causative factor for electrical remodeling in heart failure has not been determined despite the known association of ion channel changes with arrhythmogenesis.
Absolute Event Rate: 1.54% vs 1.12%
p-value: p=<0.05
Periostin decreases cardiac voltage-gated Na+ channel expression and current in rat ventricles, suggesting a potential mechanism for electrical remodeling in heart failure.
Periostin may modulate ventricular Na+ channels in rodents; hypothesis-generating for electrical remodeling in heart failure, not yet clinically relevant.
Changes in electrophysiological properties, such as ion channel expression and activity, are closely related to arrhythmogenesis during heart failure (HF). However, a causative factor for the electrical remodeling in HF has not been determined. Periostin (POSTN), a matricellular protein, is increased in heart tissues of patients with HF. In the present study, we investigated whether a single injection of POSTN affects the electrophysiological properties in rat ventricles. After male Wistar rats were intravenously injected with recombinant rat POSTN (64 µg/kg, 24 hr), electrocardiogram (ECG) was recorded. Whole-cell patch clamp was performed to measure action potential (AP) and Na+ current (INa) in isolated ventricular myocytes. Protein expression of cardiac voltage-gated Na+ channel (NaV1.5) in isolated ventricles was examined by Western blotting. In ECG, POSTN-injection significantly increased RS height. POSTN-injection significantly delayed time to peak in AP and decreased INa in the isolated ventricular myocytes. POSTN-injection decreased NaV1.5 expression in the isolated ventricles. It was confirmed that POSTN (1 µg/ml, 24 hr) decreased INa and NaV1.5 protein expression in neonatal rat ventricular myocytes. This study for the first time demonstrated that a single injection of POSTN in rats decreased INa by suppressing NaV1.5 expression in the ventricular myocytes, which was accompanied by a prolongation of time to peak in AP and an increase of RS height in ECG.
No takes yet. Share an insight, caveat, or question.
Imoto et al. (2021) studied Healthy (investigating mechanisms relevant to heart failure) (n=30). Periostin (POSTN) vs. Vehicle was evaluated on RS height on electrocardiogram (mV) (p=<0.05). A single injection of periostin significantly increased RS height on electrocardiogram (1.54 vs 1.12 mV) and decreased cardiac voltage-gated Na+ channel expression in rat ventricles.
Synapse has enriched 5 closely related papers on similar clinical questions. Consider them for comparative context: